Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylos (Q38010372)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylos	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylos (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

quality of life

1 reference

based on heuristic

inferred from title

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

author name string

Jane Zochling

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

63 Suppl 11

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

S47-58

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

How to measure disease activity in axial spondyloarthritis?

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Quality of life and related variables in patients with ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

The ankylosing spondylitis quality of life questionnaire: validation in a New Zealand cohort

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Patient-assessed health in ankylosing spondylitis: a structured review

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Factors related to change in global health after group physical therapy in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: a translation, cross-cultural adaptation, and validation

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20575

21 January 2018

Identifiers

10.1002/ACR.20575

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38010372&oldid=1524442978"